Suppr超能文献

特鲁纳特(Truenat)对尼日利亚结核病诊断的影响。

Impact of Truenat on TB diagnosis in Nigeria.

作者信息

Eneogu R, Olabamiji J, Ihesie A, Nwokoye N, Ochei K, Nwadike P, Salau O, Munguno Z, Odume B, Agbaje A, Nongo D, Oyelaran O, van Germert W, Mupfumi L, Emeka E, Anyaike C, Ossai E N

机构信息

HIV AIDS & TB Office, USAID Nigeria, Abuja.

HIV-Nigeria, Lagos, Nigeria.

出版信息

Public Health Action. 2024 Sep 1;14(3):124-128. doi: 10.5588/pha.24.0021. eCollection 2024 Sep.

Abstract

OBJECTIVE

To evaluate the impact of Truenat assays on the diagnosis of TB at peripheral facilities in Nigeria.

METHODS

This was a retrospective cross-sectional study across 34 out of 38 Truenat-implementing facilities in Nigeria. These facilities offer DOTS services. Information on turnaround time (TAT) for TB diagnosis and time to commencement of treatment was obtained. Also, trends in TB case notifications at the facilities 9 months prior to and 9 months during Truenat implementation were compared.

RESULTS

Of 2,335 entries, 70.1% (1,636) were used to determine TAT, while 45.8% ( = 1,070) were used for time to treatment initiation. The median time to diagnosis was <24 hours (IQR 0-1 days). The majority (57.9%) were diagnosed in <24 hours. The median time to treatment initiation was 1.5 days (IQR 0-3). In 9 months before the introduction of Truenat, 8% of 20,424 presumptives evaluated were positive for TB, while during the implementation, 9% of 37,087 presumptives were positive for TB.

CONCLUSION

Truenat deployment led to an increase in TB and DR-TB case detection in peripheral facilities in Nigeria. It also decreased TAT and time to TB treatment initiation. These have positive implications in the fight against TB, and Truenat is relevant in finding missing TB cases in Nigeria.

摘要

目的

评估Truenat检测对尼日利亚基层医疗机构结核病诊断的影响。

方法

这是一项对尼日利亚38家采用Truenat检测的医疗机构中的34家进行的回顾性横断面研究。这些医疗机构提供直接观察短程化疗(DOTS)服务。获取了结核病诊断的周转时间(TAT)和开始治疗时间的信息。此外,还比较了Truenat检测实施前9个月和实施期间9个月各医疗机构结核病病例报告的趋势。

结果

在2335份记录中,70.1%(1636份)用于确定TAT,而45.8%(即1070份)用于确定开始治疗的时间。诊断的中位时间<24小时(四分位间距0 - 1天)。大多数(57.9%)在<24小时内得到诊断。开始治疗的中位时间为1.5天(四分位间距0 - 3天)。在引入Truenat检测前的9个月里,20424名疑似患者中有8%结核病检测呈阳性,而在实施期间,37087名疑似患者中有9%结核病检测呈阳性。

结论

在尼日利亚基层医疗机构中,采用Truenat检测导致结核病和耐多药结核病病例检出率增加。它还缩短了TAT和结核病开始治疗的时间。这些对结核病防治具有积极意义,并且Truenat检测在发现尼日利亚漏报的结核病病例方面具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8915/11373742/ec14249e92b4/pha24-0021f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验